Brief: Point Biopharma Announces Publication Of Findings From Of Splash Trial In MCRPC

POINT Biopharma Global

25/02/2022 14:46

Feb 25 (Reuters) - POINT Biopharma Global Inc  PNT.O :
    * POINT BIOPHARMA ANNOUNCES ABSTRACT PUBLICATION OF
DOSIMETRY DATA
FINDINGS FROM THE LEAD-IN COHORT OF THE SPLASH TRIAL IN MCRPC AT
THE 2022 SNMMI MID- WINTER & ACNM ANNUAL MEETING
    * POINT BIOPHARMA GLOBAL- DOSIMETRY DATA DEMONSTRATED
PNT2002 HAS
FAVORABLE, SAFE DOSIMETRY PROFILE IN PATIENT POPULATION AND DOSE
REGIMEN BEING STUDIED
    * POINT BIOPHARMA GLOBAL INC- RED MARROW DOSIMETRY WAS WELL
BELOW
CRITICAL THRESHOLDS, ENABLING A POTENTIAL OPPORTUNITY FOR
COMBINATION THERAPY

Further company coverage:  PNT.O 

 ((reuters.briefs@thomsonreuters.com;))